HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Role of Cardiac MR Imaging in the Assessment of Patients with Cardiac Amyloidosis.

Abstract
Despite recent advancements in newer biomarkers development and improved imaging techniques, the diagnosis of cardiac amyloidosis (CA) remains a frequent clinical challenge. In this setting, cardiac MR (CMR) imaging has emerged as a powerful tool to assess heart morphology and function, with the unique advantage of noninvasive tissue characterization. This article summarizes the CMR imaging common findings in CA and the latest research in this field, including delayed enhancement, native T1 mapping, and extracellular volume quantification.
AuthorsFilipe Penna de Carvalho, Fernanda Erthal, Clerio F Azevedo
JournalMagnetic resonance imaging clinics of North America (Magn Reson Imaging Clin N Am) Vol. 27 Issue 3 Pg. 453-463 (Aug 2019) ISSN: 1557-9786 [Electronic] United States
PMID31279449 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2019 Elsevier Inc. All rights reserved.
Topics
  • Amyloidosis (diagnostic imaging)
  • Heart (diagnostic imaging)
  • Heart Diseases (diagnostic imaging)
  • Humans
  • Magnetic Resonance Imaging (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: